Vical Incorporated (Nasdaq: VICL) announced that the company will present an update on its investigational antifungal product candidate, VL-2397, at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE